Holocene Advisors’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $56.6M | Buy |
+1,809,475
| New | +$56.6M | 0.14% | 153 |
|
|
2023
Q4 | – | Sell |
-178,470
| Closed | -$6.1M | – | 849 |
|
|
2023
Q3 | $6.1M | Sell |
178,470
-534,008
| -75% | -$18.2M | 0.03% | 353 |
|
|
2023
Q2 | $27.4M | Sell |
712,478
-273,717
| -28% | -$10.5M | 0.12% | 182 |
|
|
2023
Q1 | $35.3M | Sell |
986,195
-205,443
| -17% | -$7.35M | 0.17% | 157 |
|
|
2022
Q4 | $47M | Sell |
1,191,638
-637,514
| -35% | -$25.1M | 0.29% | 107 |
|
|
2022
Q3 | $66M | Hold |
1,829,152
| – | – | 0.42% | 82 |
|
|
2022
Q2 | $55.6M | Buy |
1,829,152
+919,524
| +101% | +$28M | 0.34% | 102 |
|
|
2022
Q1 | $27.8M | Buy |
+909,628
| New | +$27.8M | 0.14% | 160 |
|